These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 1370092)

  • 1. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.
    Green KY; Kapikian AZ
    J Virol; 1992 Jan; 66(1):548-53. PubMed ID: 1370092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination.
    Taniguchi K; Urasawa T; Kobayashi N; Ahmed MU; Adachi N; Chiba S; Urasawa S
    J Clin Microbiol; 1991 Mar; 29(3):483-7. PubMed ID: 1709946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.
    Johansen K; Svensson L
    Arch Virol; 1997; 142(7):1491-8. PubMed ID: 9267458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
    Gorrell RJ; Bishop RF
    J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.
    Menchaca G; Padilla-Noriega L; Méndez-Toss M; Contreras JF; Puerto FI; Guiscafré H; Mota F; Herrera I; Cedillo R; Muñoz O; Ward R; Hoshino Y; López S; Arias CF
    Clin Diagn Lab Immunol; 1998 May; 5(3):328-34. PubMed ID: 9605987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays.
    Matson DO; O'Ryan ML; Pickering LK; Chiba S; Nakata S; Raj P; Estes MK
    J Clin Microbiol; 1992 May; 30(5):1056-61. PubMed ID: 1374761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
    Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
    Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.
    Gorziglia M; Larralde G; Kapikian AZ; Chanock RM
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7155-9. PubMed ID: 1698292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
    Kobayashi N; Taniguchi K; Urasawa S
    Arch Virol; 1991; 117(1-2):73-84. PubMed ID: 1706592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.
    Ciarlet M; Hidalgo M; Liprandi F
    Arch Virol; 1996; 141(3-4):601-14. PubMed ID: 8645098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.
    Ward RL; McNeal MM; Sander DS; Greenberg HB; Bernstein DI
    J Virol; 1993 Jan; 67(1):464-8. PubMed ID: 8416378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
    Green KY; Taniguchi K; Mackow ER; Kapikian AZ
    J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains.
    Contreras JF; Menchaca GE; Padilla-Noriega L; Tamez RS; Greenberg HB; López S; Arias CF
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):506-8. PubMed ID: 7583936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.
    Ciarlet M; Hidalgo M; Gorziglia M; Liprandi F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1867-73. PubMed ID: 7519247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus.
    Brüssow H; Offit PA; Gerna G; Bruttin A; Sidoti J
    J Virol; 1990 Sep; 64(9):4130-6. PubMed ID: 2166808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP4 and VP7 typing using monoclonal antibodies.
    Coulson BS
    Arch Virol Suppl; 1996; 12():113-8. PubMed ID: 9015108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.
    Gorrell RJ; Bishop RF
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):509-14. PubMed ID: 9302196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.
    Chen DY; Estes MK; Ramig RF
    J Virol; 1992 Jan; 66(1):432-9. PubMed ID: 1370090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y; Saif LJ; Sereno MM; Chanock RM; Kapikian AZ
    J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.